Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Naman · SciRah

Researcher profile · Semantic Scholar

H. Naman

Share profile

H. Naman — researcher profile on SciRah

h-index: 7
Works: 21
Citations: 371

Most-cited papers

Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial.
F. Bidard, W. Jacot, Nicolas Kiavue, S. Dureau +21 more
2020JAMA Oncology151 citations Open access
Semantic Scholar
Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.
J. Doyen, C. Alix-Panabières, P. Hofman, S. Parks +3 more
2012Critical reviews in oncology/hematology80 citations
Semantic Scholar
Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.
J. Gligorov, X. Pivot, W. Jacot, H. Naman +9 more
2015The Oncologist45 citations Open access
Semantic Scholar
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
M. Pertesi, M. Vallée, Xiaomu Wei, M. Revuelta +88 more
2019Leukemia41 citations Open access
Semantic Scholar
Abstract GS3-07: Clinical utility of circulating tumor cell count as a tool to chose between first line hormone therapy and chemotherapy for ER+ HER2- metastatic breast cancer: Results of the phase III STIC CTC trial
F. Bidard, W. Jacot, S. Dureau, E. Brain +17 more
2019General Session Abstracts40 citations
Semantic Scholar
High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma
N. Martin, D. Borchiellini, D. Coso, L. Gastaud +11 more
2015Leukemia and Lymphoma23 citations
Semantic Scholar
Prospective study of the impact of using the 21-gene recurrence score assay on clinical decision making in women with estrogen receptor-positive, HER2-negative, early-stage breast cancer in France.
J. Gligorov, X. Pivot, H. Naman, W. Jacot +10 more
201213 citations
Semantic Scholar
Maintaining professional activity during breast cancer treatment.
G. Ganem, Eric-Charles Antoine, C. Touboul, H. Naman +8 more
2016European Journal of Cancer Care9 citations Open access
Semantic Scholar
[Sarcoma of the spermatic cord. Report of 2 cases. Review of the literature].
Masson Jc, Varini Jp, J. Masson, H. Naman +1 more
1992Progrès en urologie (Paris)6 citations
Semantic Scholar
First line hormone therapy vs chemotherapy for HR+ HER2- metastatic breast cancer in the phase III STIC CTC trial: clinical choice and validity of CTC count
F. Bidard, E. Brain, W. Jacot, T. Bachelot +16 more
20161 citations Open access
Semantic Scholar
[Breast cancer induced by estrogens in a prostate cancer patient].
A. Suhler, H. Naman, R. Masselot, J. Varini +1 more
1983Journal d'urologie1 citations
Semantic Scholar
[Apparently primary malignant secreting renal lymphoma (immunocytoma)].
A. Suhler, H. Naman, J. Varini, J. Donnadieu +2 more
1983Journal d'urologie1 citations
Semantic Scholar
Utilisation et besoin des patients en soins de support au cours de la prise en charge du cancer du poumon
J. Morere, F. Eisinger, H. Naman, R. Sellami +4 more
2019Revue des maladies respiratoires0 citations
Semantic Scholar
Abstract P1-11-23: Patient care in breast cancer: Unmet and fulfilled needs
Hélène Simon, J. Viguier, H. Naman, C. Touboul +4 more
2019Poster Session Abstracts0 citations
Semantic Scholar
Abstract CT140: Circulating tumor cells as a tool to guide first line therapy in metastatic breast cancer: subgroup analyses of the STIC CTC Phase III utility trial
F. Bidard, W. Jacot, S. Dureau, E. Brain +17 more
2019Clinical Trials0 citations
Semantic Scholar
Roadmap for supportive care according to patients' perspectives.
F. Eisinger, Hélène Simon, G. Ganem, C. Touboul +4 more
20180 citations
Semantic Scholar
Supportive care: Patient expectations, availability and uptake.
H. Simon, J. Viguier, G. Ganem, C. Touboul +4 more
2018Annals of Oncology0 citations Open access
Semantic Scholar
P2.15-17 Patient Care in Advanced Lung Cancer: Unmet Needs
J. Morère, F. Eisinger, H. Naman, R. Sellami +4 more
2018Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
277PBREAST CANCER: ARE EMPLOYMENT AND THERAPY COMPATIBLE, AND FOR WHOM?
Eric-Charles Antoine, G. Ganem, C. Touboul, H. Naman +8 more
2014Annals of Oncology0 citations Open access
Semantic Scholar
Continuing to work while receiving cancer treatment: A financial or a symbolic issue?
G. Ganem, H. Naman, N. Dohollou, Thomas Facchini +7 more
20130 citations
Semantic Scholar
Étude prospective de l’impact de l’utilisation du test de 21 gènes, le Recurrence Score, sur les décisions thérapeutiques prises chez les femmes ayant un cancer du sein à un stade précoce HER2 négatif et avec des récepteurs aux œstrogènes positifs
J. Gligorov, X. Pivot, H. Naman, W. Jacot +9 more
20130 citations Open access
Semantic Scholar
[Clonal eosinophilia revealed by recurrent Staphylococcus aureus infection].
F. Vandenbos, M. Figueredo, M-C Dumon-Gubeno, I. Nicolle +4 more
2011Revue de Pneumologie Clinique0 citations
Semantic Scholar
Hyperéosinophilie clonale révélée par une infection récurrente à Staphylococcus aureus
F. Vandenbos, M. Figueredo, M.-C. Dumon-Gubeno, I. Nicolle +4 more
20110 citations
Semantic Scholar
Retrospective study of RIT (radiolabelled immunotherapy) with 90Y-IT (90Y-ibritumomab tiuxetan) in relapsing FL (follicular lymphoma) after autologous (BM) bone marrow transplant (ABMT)
F. Peyrade, C. Triby, B. Slama, X. Fontana +7 more
20080 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

W. Jacot×7
Invite
W. Jacot — researcher profile on SciRah
F. Eisinger×7
Invite
F. Eisinger — researcher profile on SciRah
J. Gligorov×5
Invite
J. Gligorov — researcher profile on SciRah
C. Alix-Panabières×5
Invite
C. Alix-Panabières — researcher profile on SciRah

×5

Invite

G. Ganem — researcher profile on SciRah

Invite

F. Bidard — researcher profile on SciRah

Invite

E. Brain — researcher profile on SciRah

Invite

T. Bachelot — researcher profile on SciRah

H. Bourgeois×4

Invite

H. Bourgeois — researcher profile on SciRah

A. Gonçalves×4

Invite

A. Gonçalves — researcher profile on SciRah

Invite

S. Ladoire — researcher profile on SciRah

Invite

F. Dalenc — researcher profile on SciRah